Clinical trial of AMZ 0026 in patients with HIV-1 infections who are receiving highly active antiretroviral therapy (HAART).

Trial Profile

Clinical trial of AMZ 0026 in patients with HIV-1 infections who are receiving highly active antiretroviral therapy (HAART).

Planning
Phase of Trial: Phase II

Latest Information Update: 20 Mar 2012

At a glance

  • Drugs AMZ 0026; Antivirals
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2012 Profile title is not an official title; phase is guessed. Information received in a Clinical development update from Amazon biotech (dated March 2012)
    • 20 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top